V
Voyager Therapeutics D
D
VYGR
2.91500
USD
-0.06
(-1.85%)
مغلق
حجم التداول
9,295
الربح لكل سهم
-2
العائد الربحي
-
P/E
-2
حجم السوق
161,305,740
الأخبار المقالات
العنوان: Voyager Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.